FibroBiologics, Inc. (FBLG)

NASDAQ

$1.37

$+0.02

(+1.47%)

After-Hours

FibroBiologics, Inc. (FBLG) Live Price Chart

Last updated: ⁦2026-09-25 21:22:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

FibroBiologics, Inc. (FBLG) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.37, with a market capitalization of $9.25M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.62 to $12.40. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$9.25M
Open	$1.35
Day's High	$1,100.00
Day's Low	$0.62
Previous Close	$1.36
Volume	52.31K
Average Volume	215.97K
P/E Ratio	--
52-Week High	$12.40
52-Week Low	$0.62
Dividend Yield	--
Earnings Date	--

FibroBiologics, Inc. (FBLG) After-Hours Stock Price

FibroBiologics, Inc. (FBLG) is trading at $1.38 in after-hours trading as of 2026-09-25 20:48:00, up 1.54% ($0.02) from the regular-session close of $1.36.

After-hours trading shows how investors are pricing FBLG after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.

FibroBiologics, Inc. (FBLG) 7-Day Stock Price Change

Over the past seven days, FibroBiologics, Inc. (FBLG) moved from $1.43 to $1.37, representing a decline of 4.06% ($0.06).

The stock traded between $1.29 and $1.59 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 130.26 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

FBLG 52-Week Price Position

Position in Range: 6.4%

52W Low$0.62

52W High$12.40

FBLG is currently trading at $1.37, placing it 6.4% of the way from its 52-week low of $0.62 to its 52-week high of $12.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is FibroBiologics, Inc. (FBLG)?

FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.

FibroBiologics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	15
Exchange	NASDAQ
Company Website	https://www.fibrobiologics.com

How to Buy FibroBiologics, Inc. (FBLG) Stock on MEXC

Eligible investors can buy real shares of FibroBiologics, Inc. (FBLG) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for FBLG and Place Your Order

Open the RealStocks trading page and search for FBLG. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is FibroBiologics, Inc. (FBLG) stock price today?

FibroBiologics, Inc. (FBLG) is currently trading at $ 1.37, up 0.88% ($0.01) from the previous close of $ 1.36. Intraday prices update in real time during regular trading hours.

2.Is FBLG stock going up or down today?

As of 2026-09-25 20:48:00, FBLG is trading at $ 1.37, up 0.88% ($0.01) from its previous close of $ 1.36. The stock has traded between $ 0.62 and $ 1,100.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is FBLG pre-market price?

As of 2026-09-25 20:48:00, FBLG is trading at $ 1.34 in pre-market trading, down 1.84% ($0.03) from the previous close of $ 1.36. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is FBLG after-hours price?

As of 2026-09-25 20:48:00, FBLG is trading at $ 1.38 in after-hours trading, up 1.54% ($0.02) from the regular-session close of $ 1.36. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is FBLG stock trading now?

FBLG trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does FBLG sit relative to its 52-week high and low?

Over the past 52 weeks, FBLG has traded between a low of $ 0.62 and a high of $ 12.40. At $ 1.37, the stock is positioned 6.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is FibroBiologics, Inc. in?

FibroBiologics, Inc. (FBLG) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is FibroBiologics, Inc.'s market capitalization and where is it listed?

FibroBiologics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 9.25M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is FBLG valued in terms of P/E ratio and EPS?

FBLG trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.61. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does FibroBiologics, Inc. pay a dividend?

FibroBiologics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.